aTYR PHARMA INC Operating Leases, Future Minimum Payments, Due in Five Years
aTYR PHARMA INC (ATYR) had Operating Leases, Future Minimum Payments, Due in Five Years of $1.06 million as of 2018-09-30, per its 10-Q filed 2018-11-14.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFiveYears · last filed 2018-11-14
- 2018-09-30: Operating Leases, Future Minimum Payments, Due in Five Years $1.06M.
| Period end | Operating Leases, Future Minimum Payments, Due in Five Years |
|---|---|
| 2018-09-30 | $1.06M 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |